EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion

Lin Ai, Hangui Ren, Yuan Wang, Mengfan Liu, Yufei Qiu, Jiling Feng, Rongchen Dai, Wang Fu, Yongpeng Wang, Zhichao Xi, Hongxi Xu, Feng Wang iD

Cell Proliferation · 2026-01 · 59 (1)

DOI: 10.1111/cpr.70071 ↗

At a glance

Journal article in Cell Proliferation, published online on 2025-06-03. Written by Lin Ai and 11 co-authors. Institution: Department of Neurology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China. Major MEDLINE topics: Ginsenosides, Mitophagy, Reperfusion Injury, Neuroprotective Agents. Cited 6 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: the Postdoctoral Fellowship Program and China Postdoctoral Science Foundation, The Shanghai University of Traditional Chinese Medicine Budget Project, Shanghai Science and Technology Commission: Scientific and Technological Innovation Action Plan Medical Innovation Research Special Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ginsenoside Rg1 has shown promise in ameliorating cerebral ischemia–reperfusion injury (CIRI). However, its precise molecular mechanisms remain unclear. In this study, an in vitro CIRI model was established using SH‐SY5Y and SK‐N‐AS neuronal cell lines subjected to oxygen–glucose deprivation followed by reoxygenation (OGD/R). For the in vivo model, C57BL/6J mice underwent middle cerebral artery occlusion and subsequent reperfusion (MCAO/R). The protective effects of Rg1 against OGD/R injury were analysed using the CCK‐8 assay and the PI exclusion method. The in vivo neuroprotective effects of Rg1 against CIRI were evaluated using various assessments, including brain blood flow, neurological deficits, behavioural tests, TTC, H&E, Nissl and TUNEL staining. Mitophagy was assessed by detecting mitophagy‐initiating proteins via Western blotting, transmission electron microscopy, immunohistochemistry and immunofluorescence staining. Additionally, mitochondrial function was assessed by ATP measurement, the JC‐1 assay and MitoSOX‐based flow cytometry. Our results show that Rg1 significantly mitigated cell death caused by OGD/R and substantially enhanced cell viability in vitro. Moreover, Rg1 alleviated OGD/R‐induced mitochondrial dysfunction, as indicated by preserved mitochondrial membrane potential and decreased mitochondrial ROS levels. Mitophagy was induced after OGD treatment, which was subsequently inhibited by Rg1 during reperfusion. Mechanistically, Rg1 disrupted the fusion of mitophagosomes with lysosomes rather than inhibiting mitophagy initiation, leading to an accumulation of mitochondrial proteins and mitophagy‐initiating proteins. Notably, prolonged inhibition of mitophagy by Rg1 did not induce cytotoxicity or exacerbate mitochondrial dysfunction. Furthermore, administration of Rg1 in MCAO/R mice significantly improved brain blood reperfusion, reduced infarct volume, improved neurological deficits, preserved brain tissue integrity and decreased neuronal apoptosis. Consistent with the in vitro observations, Rg1 upregulated mitophagy‐related protein expression in MCAO/R mouse brain tissues, indicating potential inhibition of mitophagy. In conclusion, our study reveals that Rg1 significantly alleviates CIRI at least partially by suppressing mitophagy, specifically by impeding the fusion of mitophagosomes with lysosomes.

Subjects

MeSH terms (MEDLINE)

GinsenosidesMitophagyReperfusion InjuryNeuroprotective AgentsLysosomesBrain IschemiaAnimalsMice, Inbred C57BLMiceHumansMaleMitochondriaInfarction, Middle Cerebral ArteryMembrane Potential, MitochondrialReactive Oxygen SpeciesNeuronsCell SurvivalApoptosisCell Line, Tumor

Author keywords

cerebral ischemia–reperfusion injuryginsenoside Rg1ischemic strokemitophagosome‐lysosome fusionmitophagy

Substances

Ginsenosidesginsenoside Rg1Neuroprotective AgentsReactive Oxygen Species

Authors and institutions

  • Department of Neurology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.
  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID profiles: Feng Wang

Funding

  • the Postdoctoral Fellowship Program and China Postdoctoral Science Foundation
  • The Shanghai University of Traditional Chinese Medicine Budget Project
  • Shanghai Science and Technology Commission: Scientific and Technological Innovation Action Plan Medical Innovation Research Special Project
  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Super Postdoctoral Program
  • Discipline Construction of Pudong Health Bureau of Shanghai Discipline group of cerebrovascular system diseases
  • CAI Dingfang Shanghai famous traditional Chinese Medicine inheritance studio
  • Shanghai "Science and Technology Innovation Action Plan" Rising Star Program

Cite

APA

Ai, L., Ren, H., Wang, Y., Liu, M., Qiu, Y., Feng, J., Dai, R., Fu, W., Wang, Y., Xi, Z., Xu, H., & Wang, F. (2026). The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion. Cell Proliferation, 59(1). https://doi.org/10.1111/cpr.70071

Vancouver

Ai L, Ren H, Wang Y, Liu M, Qiu Y, Feng J, et al. The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion. Cell Proliferation. 2026;59(1). doi:10.1111/cpr.70071

BibTeX
@article{Ai2026,
  author = {Ai, Lin and Ren, Hangui and Wang, Yuan and Liu, Mengfan and Qiu, Yufei and Feng, Jiling and Dai, Rongchen and Fu, Wang and Wang, Yongpeng and Xi, Zhichao and Xu, Hongxi and Wang, Feng},
  title = {The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome‐Lysosome Fusion},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {1},
  doi = {10.1111/cpr.70071}
}
Start for free →